What is TheraTrue?
TheraTrue operates within the burgeoning medical cannabis industry, positioning itself as a science-driven entity focused on enhancing patient well-being. The company is committed to producing high-quality, clinically informed medical cannabis products. With a robust backing exceeding $50 million and guidance from a Medical Advisory Board comprising over 20 physicians and pharmacists, TheraTrue emphasizes rigorous scientific standards. As a majority Black-owned organization, it also champions diversity and inclusivity throughout its operations, aiming to provide secure and trusted solutions for individuals with qualifying medical conditions.
How much funding has TheraTrue raised?
TheraTrue has raised a total of $50M across 1 funding round:
Unspecified
$50M
Unspecified (2021): $50M, investors not publicly disclosed
What's next for TheraTrue?
The recent major strategic investment in TheraTrue suggests a pivotal phase of scaling and market expansion. This capital infusion is likely to accelerate product development, broaden distribution channels, and potentially support further clinical research to validate its offerings. The company's focus on a strong Medical Advisory Board indicates a commitment to evidence-based medicine, which could be a key differentiator in a regulated market. TheraTrue's emphasis on diversity and its substantial funding position it to capture significant market share while navigating the complexities of the cannabis industry.
See full TheraTrue company page
